Timothy Dixon - Therapeutic Solutions Chairman, CEO and Pres
| TSOI Stock | USD 0.0005 0.0001 16.67% |
Chairman
Mr. Timothy G. Dixon is a President, Chief Executive Officer, Director of the Company. Mr. Dixon currently serves as Chief Executive Officer, President, and Chairman of Therapeutic Solutions International, Inc. Mr. Dixon also serves as President and Chairman of OmniBiome, Inc. Mr. Dixon previously served as the President of TMD Courses, Inc. from 2006 to 2012 and as the President of Splint Decisions Inc. from 2010 to 2011. Mr. Dixon has attended hundreds of hours of continuing medicaldental education throughout the years and has produced many educational DVDs used by dental professionals worldwide on the subject of parafunctional control, migraine prevention, therapeutic Botox injections, migraine pathophysiology, dental sleep medicine, and other therapeutic protocols. Mr. Dixon also has extensive experience in dealing with corporate compliance matters with the U.S. Food and Drug Administration, as well as many international regulatory bodies. since 2011.
| Age | 65 |
| Tenure | 13 years |
| Professional Marks | Ph.D |
| Phone | 760 295 7208 |
| Web | https://www.therapeuticsolutionsint.com |
Therapeutic Solutions Management Efficiency
The company has return on total asset (ROA) of (0.7558) % which means that it has lost $0.7558 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (12.2676) %, meaning that it created substantial loss on money invested by shareholders. Therapeutic Solutions' management efficiency ratios could be used to measure how well Therapeutic Solutions manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 2 records | CHAIRMAN Age | ||
| William Schmidt | Ensysce Biosciences | 73 | |
| Stephen Glover | ZyVersa Therapeutics | 64 | |
Management Performance
| Return On Equity | -12.27 | |||
| Return On Asset | -0.76 |
Therapeutic Solutions Leadership Team
Elected by the shareholders, the Therapeutic Solutions' board of directors comprises two types of representatives: Therapeutic Solutions inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Therapeutic. The board's role is to monitor Therapeutic Solutions' management team and ensure that shareholders' interests are well served. Therapeutic Solutions' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Therapeutic Solutions' outside directors are responsible for providing unbiased perspectives on the board's policies.
| James MD, Vice Officer | ||
| Serena Robella, Director Sales | ||
| Timothy Dixon, Chairman, CEO and Pres | ||
| Feng Lin, Chief Officer |
Therapeutic Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Therapeutic Solutions a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -12.27 | |||
| Return On Asset | -0.76 | |||
| Operating Margin | (13.37) % | |||
| Current Valuation | 21.6 M | |||
| Shares Outstanding | 2.61 B | |||
| Shares Owned By Insiders | 27.98 % | |||
| Price To Earning | (8.00) X | |||
| Price To Book | 11.55 X | |||
| Price To Sales | 81.80 X | |||
| Revenue | 145.96 K |
Currently Active Assets on Macroaxis
Other Information on Investing in Therapeutic Pink Sheet
Therapeutic Solutions financial ratios help investors to determine whether Therapeutic Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Therapeutic with respect to the benefits of owning Therapeutic Solutions security.